XML 60 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727
Share Based Payments (Tables)
3 Months Ended
May. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Assumptions used to Calculate Fair Value of Options on Date of Grant
The following assumptions were used to calculate the fair value of the Company’s options on the date of grant during the three months ended May 31, 2014 and 2015:
 
 
Three Months Ended May 31,
 
2014
 
2015
Risk-Free Interest Rate:
1.2% - 1.3%
 
1.3% - 1.4%
Expected Dividend Yield:
0%
 
0%
Expected Life (Years):
4.3
 
4.3
Expected Volatility:
72.5% - 73.9%
 
63.6% - 64.6%
Summary of Stock Options Outstanding and Activity
The following table presents a summary of the Company’s stock options outstanding at May 31, 2015, and stock option activity during the three months ended May 31, 2015 (“Price” reflects the weighted average exercise price per share; "Aggregate Intrinsic Value" dollars in thousands):
 
 
Options
 
Price
 
Weighted Average
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
Outstanding, beginning of period
5,724,446

 
$
1.76

 
 
 
 
Granted
1,452,500

 
2.07

 
 
 
 
Exercised (1)
77,500

 
0.70

 
 
 
 
Forfeited
35,000

 
2.67

 
 
 
 
Expired
69,463

 
12.81

 
 
 
 
Outstanding, end of period
6,994,983

 
1.72

 
7.1
 
$
1,443

Exercisable, end of period
4,173,396

 
1.36

 
5.8
 
$
1,376


(1) 
Summary of Nonvested Options and Changes
A summary of the Company’s nonvested options at May 31, 2015, and changes during the three months ended May 31, 2015, is presented below:
 
 
Options
 
Weighted Average
Grant Date
Fair Value
Nonvested, beginning of period
3,167,083

 
$
1.08

Granted
1,452,500

 
1.05

Vested
1,762,996

 
0.70

Forfeited
35,000

 
1.50

Nonvested, end of period
2,821,587

 
1.30

Summary of Restricted Stock Grants Outstanding and Activity
The following table presents a summary of the Company’s restricted stock grants outstanding at May 31, 2015, and restricted stock activity during the three months ended May 31, 2015 (“Price” reflects the weighted average share price at the date of grant):
 
 
Awards
 
Price
Grants outstanding, beginning of period
677,634

 
$
2.26

Granted
751,570

 
1.49

Vested (restriction lapsed)
674,070

 
1.41

Grants outstanding, end of period
755,134

 
2.25

Stock-Based Compensation Expense and Related Tax Benefits Recognized
The following table summarizes stock-based compensation expense and related tax benefits recognized by the Company during the three months ended May 31, 2014 and 2015:
 
 
Three Months Ended May 31,
 
2014
 
2015
Station operating expenses
$
402

 
$
724

Corporate expenses
546

 
1,380

Stock-based compensation expense included in operating expenses
948

 
2,104

Tax benefit
331

 

Recognized stock-based compensation expense, net of tax
$
617

 
$
2,104